Answers are grounded in this paper and cite their sources.
Background Perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) are persistent environmental contaminants that may affect vascular function. We combined network toxicology, molecular modeling, and human umbilical vein endothelial cell (HUVEC) assays to compare their predicted molecular interactions and short-term endothelial effects. Results Cross-referencing chemical-associated genes with six diabetic-complication gene sets identified JUN and TP53 as recurrent candidate nodes. Docking scores were similar, whereas 100-ns molecular dynamics and molecular mechanics Poisson–Boltzmann surface area (MM-PBSA) analyses showed lower whole-complex root mean square deviation (RMSD) and a more favorable estimated binding free energy for the PFOS–p53 model than for PFOA–p53. HUVECs were exposed to PFOA (50 µM), PFOS (50 µM), or their mixture (50 µM each). At 24 h, PFOS increased p-c-Jun/c-Jun and p-p65/p65 ratios, p53 and intercellular adhesion molecule 1 (ICAM-1) protein levels, and inflammatory gene expression, while reducing migration. All exposure conditions reduced junction numbers in a 12-h vascular-like network formation assay. The phosphorylated-to-total endothelial nitric oxide synthase (p-eNOS/eNOS) ratio was not significantly altered, and the mixture produced endpoint-dependent effects. Conclusions These results identify distinct short-term endothelial responses to PFOA and PFOS, with PFOS eliciting more pronounced inflammation-associated changes under the tested conditions.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: